ASTA Energy Solutions AG definiert Prüfer- und Vergütungsagenda für 2026
Die ASTA Energy Solutions AG hat ihre Aktionärinnen und Aktionäre zur dritten ordentlichen Hauptversammlung eingeladen. Das Treffen soll am Montag, 1. Juni 2026, um 14:00 Uhr MESZ im Hotel...
Roter Ring, blaue Forderungen: Maikundgebung der SPÖ Wien im Zeichen sozialer Anliegen
In Wien haben am Freitag die traditionellen Maifeierlichkeiten der SPÖ begonnen. Seit den frühen Morgenstunden zogen Delegationen aus den Bezirken durch die Innenstadt in Richtung Rathausplatz,...
Von Sensorverkauf zu Smart-Glass-Offensive: ams-Osram ordnet Portfolio neu
Der Halbleiter- und Lichtkonzern ams-Osram stellt sein Geschäftsportfolio neu auf und setzt dabei verstärkt auf Wachstumsmärkte wie Komponenten für Augmented-Reality-Brillen und intelligente...
Semperit-Übernahmeofferte: Vorstand und Aufsichtsrat skizzieren Pro und Contra
Die Semperit AG Holding hat ihre mit Spannung erwartete Stellungnahme zum freiwilligen Übernahmeangebot der B&C Holding Österreich GmbH vorgelegt – ohne eine klare Empfehlung für oder gegen...
Diplomatische Spannungen: Russland kündigt Reaktion auf Ausweisungen in Österreich an
Österreich hat wegen mutmaßlicher Abhör-Spionage drei Mitarbeiter der russischen Botschaft in Wien ausgewiesen und damit seinen Kurs gegenüber ausländischen Geheimdiensten deutlich verschärft....

Queen Mary University of London and MCatalysis Awarded EPSRC and Defra Grant to Revolutionize Medical Waste Upcycling

19.05.2026

LONDON, May 19, 2026 /PRNewswire/ -- Queen Mary University of London (QMUL) and deep-tech company MCatalysis, Inc. have been awarded a strategic grant through the EPSRC and Defra Research to Advance UK Recycling Capabilities programme. The joint initiative, "Microwave-Catalytic Upcycling of Medical Waste: A Decentralised Solution for Resource Recovery in Healthcare," will pioneer a decentralized, modular approach to managing hazardous and complex healthcare waste streams.

MCatalysis, Inc. logo

Regulated medical waste typically comprises 10% of facility waste by volume but 50% of cost. By processing clinical plastic waste into valuable chemicals and fuels onsite, MCatalysis targets a 95% reduction in waste volume and 80% reduction in cost. Currently, the healthcare sector relies heavily on carbon-intensive incineration, contributing ~5% of global emissions; more than either the airline or maritime industries at 3%, each.

"This new funding is a critical catalyst for translating laboratory innovation into real-world impact," said Prof. Michael Jie, Principal Investigator and Chief Technology Officer at MCatalysis. "Medical waste is notoriously difficult to recycle due to contamination. By utilizing highly targeted microwave catalysis, we can break down these challenging polymers efficiently, setting a new standard for resource recovery in the UK."

"Incinerating medical waste is a 20th-century approach to a 21st-century problem," said Dr. Michael D. Irwin, CEO of MCatalysis, Inc. "We are advancing a decentralized model that places our MCatalysis platform at the source. This fundamentally rethinks resource utilization and turns an environmental liability into a secure supply of high-value chemical feedstocks and fuels."

Highlighting the national significance of the initiative, Dr Kedar Pandya, Executive Director for Strategy at EPSRC, said:

"This investment reflects our commitment to building a cleaner, more sustainable UK economy. By funding ambitious, collaborative and impactful research into recycling technologies, we are helping to tackle some of the most complex challenges in our waste system, from collection through to currently hard-to-recycle material recovery. The research being undertaken, jointly funded by EPSRC and Defra, will support the long-term transition to a circular economy and create the conditions for genuine economic and environmental benefit for the UK."

The project comprises a prestigious consortium led by QMUL in collaboration with Barts Health NHS Trust, Cardiff University, and Imperial College London. The R&D will be driven out of Prof. Jie's labs at QMUL in close collaboration with MCatalysis. Pilot-scale validation will occur at MCatalysis's existing commercialization R&D facility at Axel'One in Lyon, France.

About MCatalysis, Inc.

MCatalysis, Inc. is a deep-tech company focused on industrial electrification and the circular economy, converting waste carbon into high-value chemicals, SAF, and e-fuels. It has operations in Dallas, London, and Lyon.

About Queen Mary University of London

QMUL is a leading research-intensive university committed to addressing global challenges through innovation and sustainable chemistry.

Please send press inquiries to: media@mcatalysis.com

Logo - https://mma.prnewswire.com/media/2766750/MCatalysis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/queen-mary-university-of-london-and-mcatalysis-awarded-epsrc-and-defra-grant-to-revolutionize-medical-waste-upcycling-302775861.html